Soleil Securities
http://www.soleilgroup.com/index.shtmlSoleil Securities provides equity research for institutional investors.
View Older Stories View More Recent Stories
-
Daily State of the Markets: Surprised and Frightened?
-
Soleil Securities Presents Pairs Trade Opportunity; Upgrades MGM Mirage (MGM), Downgrades Las Vegas Sands (LVS)
-
Soleil Securites Maintains a 'Buy' Rating on United Natural Foods (UNFI); Raises PT
-
Daily State of the Markets 8/30: Bounce or New Beginning?
-
Soleil Securities Maintains a 'Hold' on Collective Brands (PSS); Cheap but no catalyst, and Headwinds Beginning in Back Half of Year
-
SunPower (SPWRA) Shines Bright on Raymond James, Soleil Dual Upgrades; Shares Up Over 10%
-
Morning Movers: NZ, PAR, DLLR, MCRS, ARUN, SPWRA, BEBE, ARST, FIRE, TSO Higher; IMGN JGG, TIF
-
Notable Analyst Rating Changes 08/27: SPWRA, GOK, TSO, MW Upgraded; VSAT, FBR Downgraded
-
Daily State of the Markets 8/27: Fear of Phrasing
-
Soleil Securities Upgrades SunPower (SPWRA) to Buy
-
Jo-Ann Stores (JAS) Crushes Q2 Views, Raises Guidance
-
Soleil Securities Maintains a 'Hold' on Shoe Carnival (SCVL); Price Target Cut on FY12 Visibility
-
Soleil Securities Maintains a 'Buy' on Jo-Ann Stores (JAS); Raises PT
-
Soleil Securities Maintains a 'Hold' on The Hain Celestial Group (HAIN); Lowering F2011 EPS Estimate, Raising Price Target
-
Daily State of the Markets 8/23: The Big Question
-
Soleil Raises Integrys Energy (TEG) to Hold, Price Target Up to $45.25
-
Soleil Starts Hospital Sector at Positive LT Outlook: HMA at Buy, LPNT, CYH at Hold
-
Soleil Ups Target on Lear (LEA) to $82 Amid Solid 1H Performance
-
Soleil Ranks Banks on Largest Increase/Decrease in Revenue/Share (NYB, PNC, WFC, C, CRBC, BPOP)
-
Soleil Securities on TJX (TJX): 'Buy on Weakness'
-
Soleil Starts Sonoco Products (SON) at Buy, $40 Target
-
Myriad Genetics (MYGN) Shares Slightly Lower Following Q4 Results, FY11 Guidance; Soleil Cuts Price Target to $20
-
Notable Analyst Rating Changes 08/11: LDK, BPO, SPWRA, NRGY Upgraded; MYGN, PBR, TWTC, TSCO Downgraded
-
Soleil Upgrades Applied Industrial (AIT) to Buy, Price Target Up to $42
-
Soleil Upgrades LDK Solar (LDK) Following Q2 Beat and Strong Guidance
-
Notable 52-Week High's and Low's of the Day 08/10: AAU, FOSL, IT High; STX, SD, MR, JAG, SCLN Low
-
Earnings Preview: Disney (DIS) Should See a Strong Quarter from Ad Sales, Increased Pricing (NWSA, CBS, TWX)
-
Clear Channel (CCO) Target Raised to $14 at Wedbush
-
Soleil Ups Price Target on MBIA (MBI) to $15 Following Q2 Results
-
Morning Movers 8/10: CCBP, RMX, ZSTN, QNST, DUCK, PSEM Higher; CYRX, SCLN, HQS, ABK, JAG, PEGA, AGM, ANSW, MR Lower
-
Mindray Medical (MR) Downgraded to Hold at Soleil, Price Target Slashed to $27
-
Unusual 11 Mid-Day Movers 08/05: HAUP, AFFY, ATML, FSYS, SNIC, RGS Higher; IKAN, PACR, TFSL, FRZ, ALXA Lower
-
Notable Analyst Rating Changes 08/05: SIRI, PCS, RGS, ACAS Upgraded; VMC, SD, CNW, Q Downgraded
-
Morning Movers 8/5: HAUP, ATML, PPO, HGG, RGS, CATM, SOLR, SNIC Higher; IKAN, PACR, ALXA, LINC, SD Lower
-
Soleil Raises Regis (RGS) to Buy as Co. to Explore Strategic Alternatives
-
Daily State of the Markets 8/5: Modest At Best?
-
Soleil Raises Target on priceline.com (PCLN) to $290, Buy Rating Maintained
-
Soleil Cuts Price Target on Bio-Rad (BIO) to $114
-
Notable Analyst Rating Changes 08/04: LEAP, BKS, MET, SQNM Upgraded; BHI, DOW, AEP, ARNA Downgraded
-
Soleil Securities Upgrades Sequenom (SQNM) to Buy
-
Soleil Cuts Price Target on MEMC (WFR) to $18, Buy Rating Maintained
-
Gentex (GNTX) Raised to Buy at Soleil Securities
-
Soleil Raises Penske (PAG) to Buy, Price Target Goes Up to $20
-
Soleil Raises DENTSPLY (XRAY) from Hold to Gradually Accumulate
-
Soleil Defends Symantec (SYMC) Amid 10% Sell-Off; Cuts Price Target to $20 But Reiterates Buy
-
Soleil Securities Downgrades Southern Co. (SO) to Hold
-
Soleil Cuts Stericycle (SRCL) to Hold Amid Q2 Results
-
Soleil Lifts Price Target on DuPont (DD) to $54; Remains a 'Top Pick'
-
Soleil Bumps Price Target on priceline.com (PCLN) to $266
-
Ford (F) Excites Wall Street After Blow-Out Q2 Results, Even Naysayers See a Higher Share Price
